Clinical Trials in Nashville

Showing 4581-4600 of 20,298 trials

HPC Offered for PRESERVE Expansion

NCT07145411

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product

Bone Marrow Transplant (BMT)

Ossium Health, Inc.10 participantsStarted Jun 2024

Birmingham, Alabama, United States • Detroit, Michigan, United States • Columbus, Ohio, United States +1 more locations

COMPLETEDPhase 1< 1 mile

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

NCT04772989

This is a Phase 1/1b, multicenter, open-label, dose-escalation, and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and clinical activity of AB308 in combination with zimberelimab (AB122) in participants with advanced malignancies.

Advanced Solid TumorNon Small Cell Lung Cancer (NSCLC)Melanoma+7 more

Arcus Biosciences, Inc.94 participantsStarted Mar 2021

Los Angeles, California, United States • Jacksonville, Florida, United States • Goshen, Indiana, United States +19 more locations

HPC Offered for PRESERVE Expansion

A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies

Find Trials by Condition in Nashville

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

Symptom Management Implementation of Patient Reported Outcomes in Oncology

A Study to Test the Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Left Ventricular Systolic Dysfunction

Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

Study of PF-07265807 in Participants With Metastatic Solid Tumors.

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

MarginProbe 2.0 Data Collection Protocol

A Pilot Randomized Controlled Trial for Hand Osteoarthritis

Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD

An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type I (MPS I)